- About MEDx
- Technology Centers
- Pharma Solutions
-
Products
IHC-Based AssaysPCR-Based AssaysNGS-Based AssaysMore AssaysCustomized AssaysSolid Tumor - Pan-Solid Tumors - Lung Cancer - Stomach Cancer - Breast Cancer - Soft Tissue Sarcoma - Other Cancer Types
Solid TumorBlood CancerRUO ProductsIVD/CDx Products - Clinical Testing
- Quality Systems
- Events
- Contact Us
Mismatch Repair (MMR) occurs in the process of DNA replication, recombination and damage repair, and can recognize and repair erroneous insertions, deletions and integrations. Four common mismatch repair proteins in the human body, namely hMLH1, hMSH2, hMSH6, and hPMS2, cooperate each other to perform DNA mismatch repair functions. The deletion of any protein in the MMR system will lead to DNA mismatch repair deficiency (dMMR), resulting in replication errors or microsatellite instability (MSI), which in turn induces tumorigenesis.
MEDx Translational Medicine's dMMR antibody detection kit detects the expression of four proteins of MLH1, MSH2, MSH6 and PMS2 in tumor tissues by immunohistochemistry (IHC).
•PMS2 Antibody Reagent Su Su Machinery No. 20180570
•MSH6 Antibody Reagent Su Su Machinery No. 20180569
•MSH2 Antibody Reagent Su Su Machinery No. 20180568
•MLH1 Antibody Reagent Su Su Machinery No. 20180519
•Higher Authority: Using the IHC antibody combination recommended by NordiQC.
•High Accuracy：Multi-platform parallel verification (MSI-PCR, MSI-NGS), high consistency and good specificity.
•Multi-platform Compatibility：All brand IHC automatic staining platforms, with a wide range of applications.
•Outstanding Convenient：The assay is easy and suitable for clinical promotion.
If you have any of the following needs, feel free to contact us or email us at inquiry@MEDxTMC.net . We will reply within 24 hours.
1. Customized or bulk orders of IVD/CDx products.
2. Get a quote for IVD/CDx products
3. Become our distributor
4. Get customized pharmaceutical service solutions
5.Learn more about our technology and R&D
